BRD4 and familial pancreatic carcinoma: Since BRD4 is involved in the growth and gemcitabine chemoresistance of pancreatic cancer cells [19, 20], we suggest that LINC00346 promotes aggressiveness of pancreatic cancer cells by sponging miR-188-3p and inducing BRD4.